{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T06:56:11Z","timestamp":1794293771452,"version":"4.9.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T00:00:00Z","timestamp":1748649600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T00:00:00Z","timestamp":1748649600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project","award":["TJYXZDXK-029A"],"award-info":[{"award-number":["TJYXZDXK-029A"]}]},{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project","award":["TJYXZDXK-029A"],"award-info":[{"award-number":["TJYXZDXK-029A"]}]},{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project","award":["TJYXZDXK-029A"],"award-info":[{"award-number":["TJYXZDXK-029A"]}]},{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project","award":["TJYXZDXK-029A"],"award-info":[{"award-number":["TJYXZDXK-029A"]}]},{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project","award":["TJYXZDXK-029A"],"award-info":[{"award-number":["TJYXZDXK-029A"]}]},{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project","award":["TJYXZDXK-029A"],"award-info":[{"award-number":["TJYXZDXK-029A"]}]},{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project","award":["TJYXZDXK-029A"],"award-info":[{"award-number":["TJYXZDXK-029A"]}]},{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project","award":["TJYXZDXK-029A"],"award-info":[{"award-number":["TJYXZDXK-029A"]}]},{"DOI":"10.13039\/501100006606","name":"Tianjin Natural Science Foundation","doi-asserted-by":"crossref","award":["21JCYBJC01460"],"award-info":[{"award-number":["21JCYBJC01460"]}],"id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100016346","name":"the Second Hospital of Tianjin Medical University","doi-asserted-by":"crossref","award":["2023LC04"],"award-info":[{"award-number":["2023LC04"]}],"id":[{"id":"10.13039\/501100016346","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Science Foundation of The Tianjin Education Commission","award":["2024ZD028"],"award-info":[{"award-number":["2024ZD028"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-025-04854-x","type":"journal-article","created":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T08:29:01Z","timestamp":1748680141000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Long-term safety and efficacy of ivabradine after direct percutaneous coronary intervention in patients with acute myocardial infarction complicated by heart failure: a single-center retrospective study"],"prefix":"10.1186","volume":"25","author":[{"given":"Xiaohua","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongxin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangyin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changle","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,31]]},"reference":[{"issue":"6","key":"4854_CR1","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/0735-1097(92)90314-D","volume":"19","author":"GF Mitchell","year":"1992","unstructured":"Mitchell GF, Lamas GA, Vaughan DE, Pfeffer MA. Left ventricular remodeling in the year after first anterior myocardial infarction: a quantitative analysis of contractile segment lengths and ventricular shape. J AM COLL CARDIOL. 1992;19(6):1136\u201344.","journal-title":"J AM COLL CARDIOL"},{"issue":"3","key":"4854_CR2","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1159\/000073933","volume":"100","author":"M Manz","year":"2003","unstructured":"Manz M, Reuter M, Lauck G, Omran H, Jung W. A single intravenous dose of ivabradine, a novel I(f) inhibitor, lowers heart rate but does not depress left ventricular function in patients with left ventricular dysfunction. Cardiology. 2003;100(3):149\u201355.","journal-title":"Cardiology"},{"issue":"12","key":"4854_CR3","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1016\/j.mayocp.2014.07.017","volume":"89","author":"P Jabre","year":"2014","unstructured":"Jabre P, Roger VL, Weston SA, Adnet F, Jiang R, Vivien B, Empana JP, Jouven X. Resting heart rate in first year survivors of myocardial infarction and long-term mortality: a community study. MAYO CLIN PROC. 2014;89(12):1655\u201363.","journal-title":"MAYO CLIN PROC"},{"issue":"9","key":"4854_CR4","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1007\/s00392-021-01806-1","volume":"110","author":"J Shen","year":"2021","unstructured":"Shen J, Liu G, Yang Y, Li X, Zhu Y, Xiang Z, Gan H, Huang B, Luo S. Prognostic impact of mean heart rate by Holter monitoring on long-term outcome in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention. CLIN RES CARDIOL. 2021;110(9):1439\u201349.","journal-title":"CLIN RES CARDIOL"},{"issue":"12","key":"4854_CR5","first-page":"CD012484","volume":"12","author":"S Safi","year":"2019","unstructured":"Safi S, Sethi NJ, Nielsen EE, Feinberg J, Jakobsen JC, Gluud C. Beta-blockers for suspected or diagnosed acute myocardial infarction. Cochrane DB Syst Rev. 2019;12(12):CD012484.","journal-title":"COCHRANE DB SYST REV"},{"issue":"5","key":"4854_CR6","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.phrs.2006.03.006","volume":"53","author":"D DiFrancesco","year":"2006","unstructured":"DiFrancesco D. Funny channels in the control of cardiac rhythm and mode of action of selective blockers. Pharmacol Res. 2006;53(5):399\u2013406.","journal-title":"PHARMACOL RES"},{"issue":"1","key":"4854_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s43044-023-00351-8","volume":"75","author":"BR Sasmita","year":"2023","unstructured":"Sasmita BR, Xie S, Liu G, Zhu Y, Luo S, Huang B. Ivabradine in patients with acute ST-elevation myocardial infarction: a meta-analysis of randomized controlled trials. Egypt Heart J. 2023;75(1):25.","journal-title":"EGYPT HEART J"},{"issue":"1","key":"4854_CR8","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12916-024-03374-3","volume":"22","author":"C Dai","year":"2024","unstructured":"Dai C, Liu M, Yang Z, Li Y, Zhou Y, Lu D, Xia Y, Chen A, Li C, Lu H, et al. Real-world performance of Indobufen versus aspirin after percutaneous coronary intervention: insights from the Aspiration registry. BMC MED. 2024;22(1):148.","journal-title":"BMC MED"},{"issue":"25","key":"4854_CR9","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/sim.3697","volume":"28","author":"PC Austin","year":"2009","unstructured":"Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28(25):3083\u2013107.","journal-title":"STAT MED"},{"issue":"Pt 6","key":"4854_CR10","doi-asserted-by":"publisher","first-page":"137431","DOI":"10.1016\/j.ijbiomac.2024.137431","volume":"282","author":"D Zhu","year":"2024","unstructured":"Zhu D, Zhang X, Fang Y, Xu Z, Yu Y, Zhang L, Yang Y, Li S, Wang Y, Jiang C, et al. Identification of a lactylation-related gene signature as the novel biomarkers for early diagnosis of acute myocardial infarction. Int J Biol Macromol. 2024;282(Pt 6):137431.","journal-title":"INT J BIOL MACROMOL"},{"issue":"4","key":"4854_CR11","first-page":"318","volume":"8","author":"L Nepper-Christensen","year":"2019","unstructured":"Nepper-Christensen L, L\u00f8nborg J, Ahtarovski KA, H\u00f8fsten DE, Kyhl K, Schoos MM, G\u00f6ransson C, Laursen PN, Sadjadieh G, Ghotbi AA, et al. Importance of elevated heart rate in the very early phase of ST-segment elevation myocardial infarction: results from the Danami-3 trial. Eur Heart J-Acute CA. 2019;8(4):318\u201328.","journal-title":"EUR HEART J-ACUTE CA"},{"issue":"2","key":"4854_CR12","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"B Ibanez","year":"2018","unstructured":"Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio A, Crea F, Goudevenos JA, Halvorsen S, et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European society of cardiology (ESC). Eur Heart J. 2018;39(2):119\u201377.","journal-title":"EUR HEART J"},{"issue":"1","key":"4854_CR13","doi-asserted-by":"publisher","first-page":"130","DOI":"10.2165\/00003495-197407010-00009","volume":"7","author":"HM Beumer","year":"1974","unstructured":"Beumer HM. Adverse effects of beta-adrenergic receptor blocking drugs on respiratory function. Drugs. 1974;7(1):130\u20138.","journal-title":"DRUGS"},{"issue":"13","key":"4854_CR14","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1001\/jama.1969.03160130055016","volume":"208","author":"ED Frohlich","year":"1969","unstructured":"Frohlich ED, Tarazi RC, Dustan HP. Peripheral arterial insufficiency. A complication of beta-adrenergic blocking therapy. Jama-J AM Med Assoc. 1969;208(13):2471\u20132.","journal-title":"JAMA-J AM MED ASSOC"},{"issue":"1","key":"4854_CR15","first-page":"CD002003","volume":"1","author":"CS Wiysonge","year":"2017","unstructured":"Wiysonge CS, Bradley HA, Volmink J, Mayosi BM, Opie LH. Beta-blockers for hypertension. Cochrane DB Syst Rev. 2017;1(1):CD002003.","journal-title":"COCHRANE DB SYST REV"},{"issue":"16","key":"4854_CR16","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.2165\/00003495-200464160-00003","volume":"64","author":"D DiFrancesco","year":"2004","unstructured":"DiFrancesco D, Camm JA. Heart rate Lowering by specific and selective I(f) current Inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease. Drugs. 2004;64(16):1757\u201365.","journal-title":"DRUGS"},{"issue":"2","key":"4854_CR17","doi-asserted-by":"publisher","first-page":"e12816","DOI":"10.1111\/anec.12816","volume":"26","author":"Y Xu","year":"2021","unstructured":"Xu Y, Zhang W, Zhong X, Yan S, Chen H, Guo R, Luo X, Liu Q. Effect of early use of ivabradine on left ventricular remodeling after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: A pilot test. Ann Noninvas Electro. 2021;26(2):e12816.","journal-title":"ANN NONINVAS ELECTRO"},{"issue":"6","key":"4854_CR18","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/0002-8703(87)90666-1","volume":"113","author":"WB Kannel","year":"1987","unstructured":"Kannel WB, Kannel C, Paffenbarger RSJ, Cupples LA. Heart rate and cardiovascular mortality: the Framingham study. AM Heart J. 1987;113(6):1489\u201394.","journal-title":"AM HEART J"},{"issue":"3","key":"4854_CR19","doi-asserted-by":"publisher","first-page":"e000668","DOI":"10.1161\/JAHA.113.000668","volume":"3","author":"JE Ho","year":"2014","unstructured":"Ho JE, Larson MG, Ghorbani A, Cheng S, Coglianese EE, Vasan RS, Wang TJ. Long-term cardiovascular risks associated with an elevated heart rate: the Framingham heart study. J AM Heart Assoc. 2014;3(3):e000668.","journal-title":"J AM HEART ASSOC"},{"issue":"1","key":"4854_CR20","doi-asserted-by":"publisher","first-page":"e000285","DOI":"10.1161\/JAHA.113.000285","volume":"3","author":"JIE Hoffman","year":"2014","unstructured":"Hoffman JIE, Buckberg GD. The myocardial oxygen supply:demand index revisited. J AM Heart Assoc. 2014;3(1):e000285.","journal-title":"J AM HEART ASSOC"},{"key":"4854_CR21","doi-asserted-by":"crossref","unstructured":"Kamisah Y, Che Hassan HH. Therapeutic use and molecular aspects of ivabradine in cardiac remodeling: A review. INT J Mol Sci 2023, 24(3).","DOI":"10.3390\/ijms24032801"},{"issue":"9744","key":"4854_CR22","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","volume":"376","author":"K Swedberg","year":"2010","unstructured":"Swedberg K, Komajda M, B\u00f6hm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet. 2010;376(9744):875\u201385.","journal-title":"Lancet"},{"issue":"10","key":"4854_CR23","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1253\/circj.CJ-19-0227","volume":"83","author":"H Tsutsui","year":"2019","unstructured":"Tsutsui H, Momomura S, Yamashina A, Shimokawa H, Kihara Y, Saito Y, Hagiwara N, Ito H, Yano M, Yamamoto K, et al. Efficacy and safety of ivabradine in Japanese patients with chronic heart Failure - J-Shift study. Circ J. 2019;83(10):2049\u201360.","journal-title":"CIRC J"},{"key":"4854_CR24","doi-asserted-by":"crossref","unstructured":"Maagaard M, Nielsen EE, Sethi NJ, Ning L, Yang SH, Gluud C, Jakobsen JC. Effects of adding ivabradine to usual care in patients with angina pectoris: a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis. Open Heart, 2020;7(2).","DOI":"10.1136\/openhrt-2020-001288"},{"issue":"3","key":"4854_CR25","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/S0735-1097(97)00527-5","volume":"31","author":"K Hu","year":"1998","unstructured":"Hu K, Gaudron P, Ertl G. Long-term effects of beta-adrenergic blocking agent treatment on hemodynamic function and left ventricular remodeling in rats with experimental myocardial infarction: importance of timing of treatment and infarct size. J AM Coll Cardiol. 1998;31(3):692\u2013700.","journal-title":"J AM COLL CARDIOL"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-04854-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-04854-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-04854-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T21:02:38Z","timestamp":1748725358000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-025-04854-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,31]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4854"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-04854-x","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,31]]},"assertion":[{"value":"10 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Second Hospital of Tianjin Medical University(KY2023K205) and the study complied with the Declaration of Helsinki. Informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"422"}}